Switch Therapeutics is based in South San Francisco. It has raised $52M in total funding. Latest round: Series A.
Switch Therapeutics is based in South San Francisco. Switch Therapeutics has raised $52M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2023. The round record for Switch Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Insight Partners, UCB Ventures, Upfront Ventures, BOLD Capital Partners, Eli Lilly and Company, Ono Venture Investment and 4 others. 10 distinct backers are named across the disclosed rounds.
Switch Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in South San Francisco below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026